scholarly journals 406P Phase 2 study of nivolumab (NIVO) in Japanese patients with previously untreated advanced melanoma: long-term efficacy and safety

2016 ◽  
Vol 27 ◽  
pp. ix126-ix127
Author(s):  
N. Yamazaki ◽  
H. Uhara ◽  
Y. Kiyohara
Keyword(s):  
Japanese Patients ◽  
Advanced Melanoma ◽  
Phase 2 ◽  
Efficacy And Safety ◽  
Term Efficacy ◽  
Phase 2 Study

scholarly journals Long‐term efficacy and safety of bexarotene for Japanese patients with cutaneous T‐cell lymphoma: The results of a phase 2 study (B‐1201)

2019 ◽  
Vol 46 (7) ◽  
pp. 557-563 ◽  
Author(s):  
Toshihisa Hamada ◽  
Yoshiki Tokura ◽  
Makoto Sugaya ◽  
Mikio Ohtsuka ◽  
Ryoji Tsuboi ◽  
...  
Keyword(s):  
T Cell ◽  
Cell Lymphoma ◽  
Japanese Patients ◽  
T Cell Lymphoma ◽  
Cutaneous T Cell Lymphoma ◽  
Phase 2 ◽  
Efficacy And Safety ◽  
Term Efficacy ◽  
Phase 2 Study

Long-term efficacy and safety of WTX101 in Wilson disease: Data from an ongoing extension of a phase 2 study (WTX101-201)

2018 ◽  
Vol 68 ◽  
pp. S105 ◽  
Author(s):  
K.H. Weiss ◽  
F. Askari ◽  
P. Ferenci ◽  
A. Ala ◽  
A. Czlonkowska ◽  
...  
Keyword(s):  
Wilson Disease ◽  
Phase 2 ◽  
Efficacy And Safety ◽  
Term Efficacy ◽  
Phase 2 Study

scholarly journals Long-term efficacy of denosumab in giant cell tumor of bone: Results of an open-label phase 2 study

2017 ◽  
Vol 28 ◽  
pp. v645-v646 ◽  
Author(s):  
E. Palmerini ◽  
J-Y. Blay ◽  
A. Le Cesne ◽  
P. Reichardt ◽  
P. Rutkowski ◽  
...  
Keyword(s):  
Giant Cell Tumor ◽  
Giant Cell ◽  
Cell Tumor ◽  
Phase 2 ◽  
Open Label ◽  
Term Efficacy ◽  
Phase 2 Study ◽  
Open Label Phase
Sign in / Sign up

Export Citation Format

Share Document